Advances in metagenomics, proteomics, metabolomics, and systems biology are providing a new emphasis in research; interdisciplinary work suggests that personalized medicine is on the horizon. These advances are illuminating sophisticated interactions between human-associated microbes and the immune system. The result is a transformed view of future prevention and treatment of chronic noncommunicable diseases, including allergy. Paradigm-shifting gains in scientific knowledge are occurring at a time of rapid global environmental change, urbanization, and biodiversity losses. Multifactorial and multigenerational implications of total environmental exposures, the exposome, require coordinated interdisciplinary efforts. It is clear that the genome alone cannot provide answers to urgent questions. Here we review the historical origins of exposome research and define a new concept, the metaexposome, which considers the bidirectional effect of the environment on human subjects and the human influence on all living systems and their genomes. The latter is essential for human health. We place the metaexposome in the context of early-life immune functioning and describe how various aspects of a changing environment, especially through microbiota exposures, can influence health and disease over the life course. (J Allergy Clin Immunol 2017;140:24-40.) 
''Human biology should be primarily concerned with the responses that the body and the mind make to the surroundings and ways of life.little effort has been made to develop methods for investigating scientifically the interrelatedness of things. Epidemiological evidence leaves no doubt that many chronic and degenerative disorders which constitute the most difficult and costly medical problems of our societies have their origin in the surroundings and in the ways of life rather than in the genetic constitution of the patient. But little is known of these environmental determinants of disease.'' -Rene J. Dubos Dubos (1901 Dubos ( -1982 addressed his colleagues in allergy and immunology with the Robert A. Cooke keynote lecture entitled ''Spaceship Earth.'' 1 For the previous decade, Dubos had been performing studies with germ-free (GF) and specific pathogenfree mice to determine the effects of nutrition, stress, maternal care, housing conditions, social interactions, and sanitation on immune function and health over the life course. His research extended into the transgenerational health effects of these variables. Much of this groundbreaking work is captured in his classic reviews 2, 3 and the book Man Adapting. 4 The message was simple and applies equally today: rapid changes in the modern environment are intertwined with immune health through synergistic biological, psychological, social, and ecological factors. Multifactorial investigations with new conceptual and experimental methods characterizing health promotion and health risks throughout life would be required to solve complex problems. Thus modernity demands a new systems approach from scientists involved in allergy and immunology. Dubos referred to this novel approach as ''environmental biology'' in the context of human ecology, a new paradigm in which single-variable examinations will not suffice. Rather, this must encompass a simultaneous merger of bench, epidemiologic, and clinical investigations with an aim toward studying a subject At the 1969 American Academy of Allergy, Asthma & Immunology meeting, Dubos made 3 additional forwardthinking arguments to his audience. First, he opined that the manifestations of allergy in the broadest sense of the term (ie, altered reactivity to the changing westernized environment) would not be fully realized for decades. In other words, he was positing that an impending epidemic of noncommunicable diseases (NCDs), including mental disorders, was not unrelated to allergy in both its narrow clinical definitions (ie, comorbidity with allergic diseases and asthma) and its etymological root (ie, ''altered reactivity'' based on an evolutionary mismatch with the total modern environment means virtually all NCDs are indeed in the realm of allergy). Second, he underscored that changes to the health of the external environment (eg, biodiversity losses and environmental degradation) were matters of importance to allergy and immunology. Third, although he conceded that much of the technology to objectively measure multiple factors, especially clinically relevant molecular biology, at community and population scales were not available (then) or cumbersome to implement (an argument that still exists), the future burden of NCDs should be enough to galvanize a different approach to population health.
Four months before the lunar landing, Dubos called for a ''massive effort similar to the one initiated by NASA'' to help allergists and immunologists understand health from the perspective of the total environment. The idea was to study genes-total environment interactions over time with exposures that also include social policies and practices. He sought not simply to understand the single or even synergistic ways in which several objectionable pollutants damage health, act as allergens, and cause altered reactivity but also to learn the elements of an environment that actually promote human health over the life course. 5, 6 He pleaded for knowledge of the total environment that equates to health wherein it is defined not simply as being free of atopic dermatitis but a state conducive to reaching human potential.
BEYOND THE GENOME
Half a century later, the total environment perspective is of massive importance not only to personal and public health but also to planetary health. The very limited causative role played by pure genetic factors in patients with chronic disease, 7 as witnessed by the tremendous global increases in NCDs, especially allergic diseases, 8 underscores the urgency of the total environment perspective. Thus despite elegant mechanistic insights provided by genome-wide association studies (GWASs), we are learning the hard way that environmental exposures, both detrimental and nourishing, manifest in personal and population health outcomes. Moreover, GWASs demonstrate that genes alone cannot explain major health disparities, nor can they explain why NCDs do not occur randomly in westernized populations. Instead, NCDs operate in a slanted direction, where the burden points to the socioeconomically disadvantaged.
The multifactorial study of health as mediated by total environmental exposures over the life course, as originally proposed, has taken various names, including the developmental origins of health and disease concept, 9 the envirome, 10 environomics, 11 and, more recently, the exposome. 12 In each case the nomenclature is unified by understanding that although genetic factors matter, total health is not a genetic trait. It is also understood that the environment is not a static variable. and certain windows of vulnerability (for disease risk) and opportunity (for health promotion) can present themselves in interactions between genes, environment, and time (Fig 1) .
Remarkable advances in objectively measured end points allow for assessments of biological tissue, immune programming, and related physiology, such as oxidative stress, hormonal activity, and neuropeptides. Moreover, the increase in high-throughput molecular -omics techniques can produce large data sets from analysis of functional proteins (proteomics), metabolites (metabolomics), gene expression (epigenomics and transcriptomics), and genetic influences on drug/isolated nutrient metabolism (pharmacogenomics). 13 The potential application of -omics in conjunction with bioinformatics and biostatistics represents an important step toward narrowing the gap between GWASs and the obvious need for environment-wide association studies of individual subjects and communities in their total dynamic environment.
Despite their many differences, NCDs are most often united by the common threads of immune dysfunction and chronic lowgrade inflammation. More recently, we are learning that alterations of the human microbiome, microorganisms, and their collective genome residing in an anatomic niche are deeply connected to most NCDs, including mental disorders. 14 In part, this might explain the high levels of overlap between NCDs, such as allergic diseases and mental disorders. 14, 15 The emerging science of the microbiome and its influence on early-life immune priming to be discussed below has forced a total environment perspective.
Although the term dysbiosis is often confined to its definition as perturbations of gut microbiota, it formally translates as ''difficult living'' or ''life in distress.'' Climate change, biodiversity losses, pollution, environmental degradation, rapid urbanization, and a general disconnection from nature are causing distress at the global scale. Planetary distress in the Anthropocene is pressing on the discipline of allergy and immunology and the patients encountered. 16 Today, we are past time for a NASA-like effort. Carefully designed, -omics-inspired megacohort studies with expert input from transdisciplinary teams will help provide a blueprint for the total environment that promotes health. Specifically, the exposome is not merely pollutants; diet, tobacco, and other lifestyle factors meet the internal/skin microbiome, and stress and immune function meet social capital, socioeconomic status, and/or the presence or absence of green space and other potentially beneficial aspects of natural environments. The term total environment can often become constricted.
We define the exposome as the aforementioned, plus the policies and practices that drive global NCDs. 17 For example, the sum of combined marketing-dietary choice evidence meets Bradford Hill Criteria for causality in public health research (ie, strength of association, dose response, and consistent biologically plausible results supported by experimental evidence). There is now clear substantiation for urgent restrictions on all forms of food marketing to children. 18 Put simply, screen-based marketing for fast food and sugar-heavy cereal should be no less a part of exposure science. Thus the exposome cannot be separated from scientific explorations of the ways in which policy influences gene-environment interactions over time. 19 Finally, in the midst of exposure science and the exposome, there is an almost exclusive focus on psychological stress. However, negative and positive emotions are not the opposite and are indeed only modestly correlated. 19 We include distinct psychological assets in our view of exposure science. For example, maternal optimism is a psychological asset associated with mental health in offspring, 20 and prospective data from the Nurses' Health Study (n 5 70,021) show that dispositional optimism in adulthood is associated with decreased risk of mortality over time. 21 Optimism and other psychological assets are associated with decreased inflammatory burden. 19 The exposome can be viewed through the prism of the holobiont (ie, human subjects and symbiotic functional microbes as a multispecies entity). 22 However, we underscore that the holobiont itself resides within a dynamic ecological theatre, one in which policy and positive psychology matter.
FUNCTIONAL STATUS OF INNATE AND IMMUNE FUNCTION DURING EARLY LIFE
Maturation of the human fetal innate immune system is initiated early during the first trimester of pregnancy, with pluripotent granuloma-macrophage progenitors appearing in the fetal circulation by week 5 and relevant precursor populations becoming detectable in the thymus and bone marrow between gestational weeks 8 to 12. The mechanisms that govern the ensuing maturation process are incompletely understood, but it is becoming clear that a variety of environmental factors acting on the mother can have profound and long-lasting effects on the immune status of their offspring and their ensuing susceptibility to a range of inflammatory diseases (discussed elsewhere in this review). In this context it is noteworthy that in parallel with events occurring within the central immune system, local regional immune functions also develop progressively during late gestation, 23 and as part of this process, embryonic innate immune cells can contribute actively to differentiation of mucosal tissues, including within the respiratory tract. 24, 25 It is also evident that as part of this maturation process, the capacity of the fetal immune system to produce certain effector molecules that are potentially toxic to normal placental function or functions, as exemplified by (but not restricted to) the T H 1 cytokine IFN-g, are selectively constrained during intrauterine development, 26 and the resultant ''functionally immature'' immunophenotype persists into infancy. This process is common to all mammalian species and involves a combination of epigenetic mechanisms that negatively regulate expression of key T H 1-trophic genes in both lymphoid and myeloid cells in the fetus and newborn 27, 28 together with indirect mechanisms involving local production of a broad range of molecules that attenuate overall capacity for T-cell activation, program antigenpresenting cells for preferential T H 2 switching, or both. [29] [30] [31] [32] [33] In contrast, T H 17 response capacity is maximal in the neonatal period. 34 In parallel, surface expression of Toll-like receptors (TLRs) on innate immune cells and associated capacity for receptor-induced intracellular signaling is not fully developed by birth. 35, 36 In broad terms the late fetal and neonatal immunophenotype is thus usually biased toward T H 2 and T H 17 immunity, whereas T H 1 capacity is attenuated. 34 Postnatal maturation of immune competence and the role of the microbial environment
The maturation of most individual innate and adaptive immune functions are essentially complete by the end of the preschool years, with the exception of a few aspects exemplified by IL-12 production capacity 37 and the airway mucosal dendritic cell (DC) ''immune surveillance'' network 38 that continues to expand until sexual maturity. It has now been recognized that the major environmental signals driving normal postnatal maturation of immunocompetence in all mammalian species emanate from the microflora of the gastrointestinal tract (GIT). Until very recently, progress in this research area has been severely constrained by the lack of technologies capable of dealing with the complexities inherent in the underlying interactions between stimulant (the microbiota) and target (the immune system). The current genomic revolution provides the necessary tools with precision that will increase exponentially over time. As discussed in the final section of this review, the data mountain being generated by these technologies has created a new set of problems, notably the need for data integration on a scale previously unknown in biology, and this is driving the rapid development of the specialty of computational biology, which is now a crucial element of research in this and related biomedical areas (see further discussion below).
As a result of recent studies, the evolving paradigm is now that colonization of the infant GIT with an ''appropriate'' microbiota within crucial developmental time windows is required to optimally drive immune function maturation, 39 but research to define what is ''appropriate'' is in its infancy. Part of this process likely involves the activity of a small range of bacterial genera releasing dietary metabolites with immunomodulatory activity that targets specific receptors on mesenchymal and immune cells, 40 but given emerging evidence of the functional importance in this context of diversity within the microbiota, 41 ,42 much more complex (and as yet Immune function maturation kinetics. Maturation of key aspects of innate and adaptive immune function is incomplete at birth, resulting in increased susceptibility to a variety of diseases, including infections and allergic sensitization. The degree of impairment of immune competence during early life is highly variable; however, children with an atopic family history cluster toward the ''slow development'' end of the population spectrum, displaying reduced functionality at birth and taking longer to attain adultequivalent levels of immune competence.
undefined) mechanisms are also undoubtedly involved. It also appears likely that the maternal microbiota will have important effects on immune function maturation in offspring, 43 as well as potential contributions from the microbiota of the infant skin 44 and airways 45 and potentially from the placenta. 46 Because the topic of the microbiome was recently extensively covered by the Journal, we refer the reader to these excellent articles. [47] [48] [49] [50] It is important to note that microbial components of the GIT microbiota can also negatively affect functional maturation of immunocompetence, as exemplified by the deleterious effects on early postnatal colonization with certain bacterial strains exemplified by Clostridium difficile in relation to risk for atopic eczema development. 51, 52 Likewise, the presence of certain bacterial pathogens in the early upper respiratory microbiota of high-risk children has been identified as an important potential risk factor for later atopic asthma development. 53 Differences in immune function maturation kinetics: Slow maturation as a risk factor for allergic disease?
Cross-sectional studies comparing infants and children at high genetic risk for allergy/asthma and associated population-based prospective birth cohort studies have identified slow postnatal maturation of immunocompetence as a risk factor for development of these diseases. During this postnatal time window (Fig 2) , high-risk children manifest lower levels of a variety of immune functions relative to the population at large, including capacity to produce IL-12, 54,55 IFN-g, 56, 57 and IL-10
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; circulating numbers and functions of DCs [59] [60] [61] ; and regulatory T-cell numbers. 62 The nature of the underlying allergy/asthma-promoting mechanisms associated with these developmental deficiencies is incompletely understood. However, it is noteworthy that heightened susceptibility to severe lower respiratory tract infection, which is a strong risk factor for development of atopic asthma, 63 has been linked to deficiencies in DCs, 59 IL-12, and/or IFN-g [64] [65] [66] and reduced IL-10 production. 58 Moreover, reduced responsiveness to common pediatric vaccines 67, 68 has also been reported as a marker of high-risk children, suggesting that the capacity to develop protective immunologic memory against pathogens is compromised in this age group. Whether this developmental deficit in high-risk children is entirely a result of compromised capacity to recognize and respond to maturation-inducing environmental microbial signals or whether a more fundamental deficit at the level of progenitor cell populations is also involved remains to The microbial exposome. Environmental microbes come from different sources, and the composition differs according to lifestyle and living conditions. Also, dietary components (eg, vegetables and fruits) harbor microbes, which are ingested. Additional sources are microbes from pets and vertebrates (eg, rodents) and nonvertebrates (eg, mites and cockroaches), which are also associated with certain pure living conditions. Mucosal contact sites are associated with ingestion and inhalation (together with absorption through the skin). Timing also plays an important role. A particular window of contact is the prenatal and early postnatal period, and mode of delivery is important. In terms of immunologic consequences, microbes trigger through pattern recognition receptors (PRRs) and activation of innate and adaptive immune responses. Epigenetic regulation plays an important role, leading to modulation of T-cell effector responses and generation of immunologic tolerance.
be established. However, it is evident from cord blood studies that this deficit in high-risk children is already evident at birth, [53] [54] [55] and it is important to note in this context that signals emanating from both the prenatal and postnatal environments are now recognized to contribute to immune function maturation (Fig 1) , as discussed further below.
EXTERNAL MICROBES, PERINATAL FACTORS, AND IMMUNE DEVELOPMENT
Development and maintenance of immunologic tolerance represents one of the key functions of our immune system. Our view of how this is regulated and controlled has recently shifted to microbes. Several concepts have been developed that focus on the coevolutionary phylogenetic adaptation of human populations to their microbial environments. 69 Just over the last century, the development of affluent lifestyles and postmodern habitats has led to skewed microbial diversity and disturbance of a humanmicrobial balance, and altered microbial exposure, particularly in early life, predisposes to development of particularly chronic inflammatory disease. 70 Prominent concepts include the hygiene hypothesis, which was originally proposed by David Strachan, 71 and, as an extension, the old friends hypothesis, which was originally developed by Graham Rook, 72 in which many infectious agents and microbes in coevolution with humans have developed mechanisms to modulate and evade the host immune system (Fig 3) . The loss of such ''old friends'' is closely linked to altered biodiversity, which is another extension of this concept. 73 
Living conditions and environmental microbes
Cross-sectional and longitudinal studies have provided important insight into the association between environmental microbial exposures and disease development. It has long been known that the traditional farming environment represents a lifestyle condition with reduced allergen asthma prevalence. Initially, surrogate markers for certain types of microbial exposure have been used to associate exposure with disease risk. This includes endotoxin (LPS) as a marker for gram-negative bacterial exposure (Protection Against the Development of Atopy: Relevant Factors for Farming Environments [ALEX] study) 74 and extracellular polysaccharide from Penicillium and Aspergillus species as a marker of fungal exposure (Prevention of Allergy-Risk Factors for Sensitization in Children Related to Farming and an Anthroposophic Life Style [PARSIFAL]), 75 but no association with b (1,3)-glucans was observed. 76 With the advent of molecular genotyping, it is now possible to pinpoint these associations to the genus and/or species level. The GABRIELA study (Multidisciplinary Study to Identify the Genetic and Environmental Causes of Asthma in the European Community) associated Penicillium, Aspergillus, and Arozium species with asthma-protective exposures. 77 Furthermore, bacterial and fungal diversity in the environment could be linked to asthma protection during childhood (Protection Against Allergy: Study in Rural Environments [PASTURE] and GABRIELA). 78 Therefore there is now strong evidence that early-life exposure to sources of rich diverse microbial populations is associated with protection. This is also supported by studies performed in the developing world with very high microbial burden, such as Papua New Guinea. 79, 80 The indoor urban environment presents an important microbial source for particularly larger cities, where an increasing amount of time is spent indoors. However, little is known about bacterial and fungal exposure under these conditions. One study performed in the Boston metropolitan area could also link endotoxin exposure and muramic acid levels as a marker for composite bacteria inversely with asthma and atopy. Furthermore, a study performed in The Netherlands (Prevention and Incidence of Asthma and Mite Allergy [PIAMA]) confirmed extracellular polysaccharide exposure and could not relate 1,3 b-Dglycans to the protected effect. [81] [82] [83] Within the indoor environment, vertebrates and nonvertebrates provide an important additional source of microbial richness. A study performed in homes of poor, inner-city households in the United States as part of a longitudinal birth cohort study found that children exposed to the highest levels of both microbes and allergens had the lowest rate of atopy. There are some initial data indicating that rodents or cockroaches in such environments can enhance the diversity of bacteria assessable to the developing infant gut microbiome. This might result in a similar effect as observed for pets, including dogs. Mice supplemented with this house dust collected from dog-keeping households were largely protected against experimental asthma, and this protection could be associated with a microbiome enriched for Lactobacillus johnsonii. A possible underlying mechanism could be linked to the production of short-chain fatty acids (SCFAs) through fermentation of complex carbohydrates by such microbes. [84] [85] [86] [87] Innate and adaptive immune response One important mode of action through which microbes trigger immune responses is through recognition of microbial motifs by pattern recognition receptors, among them TLRs. Local (mucosal) administration of natural or synthetic TLR agonists has been shown to result in protection against experimental asthma in several murine models. This includes activation of TLR2 (lipopeptides), TLR2/4 (peptide glycan), TLR4 (endotoxin), TLR3, TLR7 (polyinosinic:polycytidylic acid and R848), and TLR9 (DNA from Bordetella pertussis). [88] [89] [90] [91] [92] [93] In most of these studies, the T H 2-protective effect could be linked to development of a strong T H 1 immune response with or without increased IL-12 and/or IL-10 levels. These mechanistic studies support the results from epidemiologic studies on upregulated expression of TLRs in children either living in traditional environments, being asthma protected, or both. [94] [95] [96] As a result of this receptor-ligand interaction, the activation of TLR downstream signals has been repeatedly observed also after farm dust exposure to mice. This protection was mediated by A20, an inhibitor of transcription nuclear factor kB.
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GF mice are an indispensable model to establish a cause-andeffect relationship between microbial exposures and immune functions. GF mice have poorly developed gut and mesenteric lymphoid tissue together with decreased production of IgA and a skewed T-cell compartment. These abnormalities can be reversed by introduction of gut bacteria but only during a restricted window in early life. [98] [99] [100] Furthermore, GF lack oral tolerance 101 and are more susceptible to colitis. They have a stronger T H 2 response (higher IL-4 levels) and augmented allergic phenotypes. Colonization of GF mice with several defined bacterial species abrogated the T H 2 bias. Conversely, GF mice have a reduced T H 1 response, and oral tolerance can be restored by Bifidiobacterium infantis and other species. [101] [102] [103] [104] [105] [106] [107] [108] [109] These data not only point to the eminently important role of microbial exposure to mount proper, balanced, and tolerated immune responses but also clearly indicate the important window for opportunity in early life for shaping these types of functions.
This concept has been tested with several intact bacteria isolated from the farming environment, including cow sheds. They belong to both gram-negative and gram-positive genera, including Acinetobacter lwoffii, Lactobacillus lactis, Bacillus licheniformis, and Staphylococcus sciuri. [110] [111] [112] [113] Transmaternal asthma-protective effects were observed with Acinetobacter lwoffii, and this was dependent on intact TLR signaling in the mothers. Maternal administration augmented TLR expression patterns in the maternal lung, resulting in local and systemic mild, lowgrade inflammatory responses with IL-6, TNF-a, and IL-12,40 production. The asthma-preventive effect was also associated with modulation of TLR expression patterns in the placenta. At the level of adaptive immune responses, this protective effect was IFN-g dependent in offspring and regulated through an epigenetic mechanism. 114 This supports observations in human subjects that prenatal microbial exposures have an extensive effect on innate and adaptive immune function regulated at least in part through epigenetic mechanisms.
115-118

Transmaternal exposure
Transmaternal protection against allergic/asthmatic phenotypes throughout pregnancy might be mediated through fetal exposure to microbes. Indeed, recently, a placental microbiome has been reported with an abundant presence of bacterial genetic material. 46 Is there a role for intrauterine bacteria in gestation? This question arose from studies performed some time ago, indicating that there is a large discordance between the presence of bacteria as per culture-based diagnosis and the absence of (histological) inflammation and infection. [119] [120] [121] [122] [123] With modern genetic analysis performed in more than 300 human placental samples, a low-abundance complex community dominated by several phyla was found in nearly all placental samples. It was also found that the placental microbiome most closely resembles the oral microbiome of the supragingival plaque and the dorsum of the tongue and did not closely resemble the stool or vaginal microbiomes. It was concluded from these studies that placental bacteria are likely not ascending from a vagina or resemble contaminants of the stool but instead are possibly seeding from the oral cavity through blood spreading. 46, 124 This might explain the modified TLR expression in the placenta in murine studies. However, this research area is still in its infancy, and much more data are expected to shed light on this important field.
The next important exposome is represented by the mode of delivery. There, as vaginally delivered infants are colonized by microbiomes similar to those of their mother's vaginal tube, cesarean-born infants exhibited a different pattern. 125, 126 Gut microbiota in neonates and infants delivered by means of cesarean section show a reduced bacterial richness and diversity, a reduction in colonization by beneficial bacteria, and an increased colonization by potential pathogens, which is associated with an increased risk of asthma, allergic disorders, and other chronic inflammatory diseases. [127] [128] [129] [130] [131] Vaginal delivery was associated with increased microbial diversity in gut colonization during the neonatal and childhood period together with a decreased risk of asthma and other allergic phenotypes. 42, 125, 132, 133 However, it is important to distinguish between elective (without rupture of the membranes) and emergency cesarean section. 
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GASTROINTESTINAL TRACT, DIET, AND IMMUNE MATURATION
Much of the interface between the total environment and genes over time (ie, the exposome) occurs in the GIT. Once considered largely an interface for nutrient extraction and waste elimination, the entire GIT is now recognized as a series of highly complex microbial ecosystems. 137 The activities within these niches are far more functional than previously appreciated; each plays integral roles in metabolic, immune, neurologic, and physiologic functioning of the host. As a functional unit, microbial and human elements collectively operate to maintain homeostasis of almost all aspects of health. This underscores the importance of integrated concepts in understanding the development and integrity of the gut and the establishment of this ecological unit, in particular elements that influence initial colonization, such as perinatal antibiotics, 138 ,139 breast-feeding and feeding practices, 140 delivery method, 125 and other perinatal practices. 141 
Upstream environmental factors influence gut ecosystems
As researchers transition from observing the GIT microbiome at the phyla and genus level and move toward species and strains, it is becoming increasingly clear that the remarkably diverse functions of particular strains, most notably through their crosstalk with the immune system, might be the difference between health and disease. 142 Regardless of scale, the GIT microbiome insinuates itself into all aspects of physical and mental well-being. 143 Moreover, the upstream drivers of the dynamic GIT microbial ecosystem structure and function range from personal lifestyle choices, both current and in past life history, and outward to society-level policies. 19 According to our definition of the exposome (Fig 1) , the in situ niche at the villi is constructed by factors ranging from subtle local physiology to the policies and marketing practices that promote dysbiosis, social inequality, and the risk of NCDs. 19 
Nutrition as a centerpiece
The diet-GIT microbiome interface has received much attention because it might help provide pathways between adherence to traditional dietary patterns (exemplified by the Mediterranean diet) and reduced risks of allergic disease and mental disorders (Fig 4) . These relationships offer hope for both prevention and treatment. 144, 145 Available evidence suggests that dietary patterns affect GIT microbial diversity, which in turn influences the immune system through direct and indirect pathways. 146, 147 Indeed, although GIT microbes can communicate directly with the central nervous system through the vagus nerve, 148 the emerging science of the gut microbiome and neuropsychiatric behavior indicates that much of the microbial communication is being mediated by the immune system. 14 Loss of GIT microbial diversity through westernized dietary patterns appears to set in motion a cascade characterized by disturbances in the GIT biofilm and barrier (so-called leaky gut), endotoxin penetration, and resultant low-grade inflammatory immune response with metabolic and behavioral consequences. 149 Moreover, interaction of GIT microbes with dietary phytochemicals is a bidirectional loop, which promotes microbial diversity and reduces systemic oxidative stress and inflammatory burden. 150, 151 Geographic variations in childhood gut colonization patterns have been implicated in differential risk for allergy and autoimmunity for many years 152 ; however, new metagenomic analyses add a new dimension to this story, revealing striking differences in dominant LPS variants produced by fecal bacteria of children from regions with a high prevalence of allergy and early-onset autoimmunity. 153 Children from regions with more prevalent immune disease (Finland) show LPS subtypes with markedly reduced immunogenicity derived from Bacteroides species compared with LPS derived largely from Escherichia coli in children from areas of lower disease prevalence (Russia), reflecting recognized differences in relative species abundance. 153 This suggests that colonization early in life with a lowimmunostimulatory microbiota can impair aspects of immune programming and predispose to inflammatory diseases. 154 It also draws attention to the many wider environmental and lifestyle factors that are driving early differences in colonization and how these might be improved to prevent disease. Even inhaled particulate pollutants (below) can have toxic effects on gut microbes when they are swallowed in cleared respiratory secretions. 155 Seeing the gut microbiome through a developmental window A developmental perspective is essential when considering all aspects of the exposome, in particular gut health and immunity. 156 Accordingly, altering the intestinal microbiota during a critical developmental window has been shown to have life-long effects on the risk of immune 101 and metabolic diseases in animal models, including long-term predisposition to obesity, 157 even at extremely low doses. 158 The implications also extend to the developing brain, with evidence that the gut microbiota controls maturation and function of microglia in the central nervous system, 159 as well as early programming of hypothalamicpituitary-adrenal stress responses. 160 New human studies suggest that patterns of perinatal microbial exposure can influence cardiovascular risk, namely aortic intimal-medial thickness in early infancy, 161 further emphasizing the multisystemic nature of these effects.
Although most focus is logically on the early postnatal period, intrauterine factors also influence the development and integrity of the fetal gut 162 and the systemic propensity of inflammation. 118, 163 Elements of the mucosal immune system are already in place from 11 to 14 weeks of gestation, 164 and cytokines, allergens, and other environmental factors pass into amniotic fluid 165 to provide the first mucosal contact with the external environment well before birth. Inflammatory processes in utero, such as chorioamnionitis, induce fetal gut inflammation, with loss of tight junctional proteins 162 and transient increases in IL-4 responses and more persistent T H 17-like responses, which can still be detected a month after birth. 166 These observations suggest that antenatal factors predispose to disorders of mucosal integrity after birth, including necrotizing enterocolitis. Efforts to promote establishment of the gut microbiota in the perinatal period are highly logical, especially when these are likely to be compromised. Accordingly, a meta-analysis of 20 studies showed that neonatal probiotic supplementation markedly reduces the mortality and incidence of necrotizing enterocolitis in preterm infants (relative risk, 0.43; 95% CI, 0.33-0.56). 167 This underscores the protective role of commensal microbes in the perinatal period and strongly reinforces routine clinical use in this high-risk setting.
More subtle defects in gut integrity and the early gut microbiome 168 are also implicated in the very early immune dysregulation 169 associated with food allergy and eczema in the immediate postnatal months. 170 Under normal homeostatic conditions, the intestinal microbiome plays an essential role in maintenance of the mucosal barrier, including the mucus layer, the integrity of the epithelium, and suppression of local innate immune response. 171 This is mediated in part through production of SCFAs and other microbial metabolites, which have homeostatic and anti-inflammatory effects on local epithelial cells. 172 SCFAs also induce innate lymphoid cells to produce IL-22, thereby promoting secretion of the protective mucus layer and antimicrobial peptides by Paneth cells. 168 These and other pathways suppress inflammation and prevent uncontrolled access to the lamina propria by food antigen and potential pathogens.
Prebiotics and probiotics in the context of dysbiotic drift
For logical reasons, probiotics and prebiotics have been seen as safe and relatively simple strategies to restore gut health in many conditions that have been associated with dysbiosis or to prevent disease, including allergic disease, 173 mental health, 174 obesity, and type 2 diabetes. 175 Although it is very premature to make specific recommendations in patients with many of these conditions, some expert bodies have begun recommending prebiotics and probiotics for conditions such as allergy prevention, 176, 177 as reviewed by Forsberg et al. 173 The role in treatment is less clear, although in infants with food allergy, there is preliminary evidence that supplementation with commensal bacteria (Lactobacillus rhamnosus GG probiotics) alters the bacterial community structure more broadly to expand SCFA (butyrate)-producing bacterial strains and accelerate acquisition of tolerance. 178 Although further studies are needed, this is consistent with animal studies showing the effects of butyrate-producing microbes on regulatory T-cell induction. 179, 180 However, it would be shortsighted to focus only on supplements, such as prebiotics and probiotics, without addressing the underlying shifts in societal, environmental, and lifestyle factors that are driving dysbiotic drift on a global level. 16, 19 These societal transitions are also reflected in the microbiome, including evidence of species extinction. 181, 182 Dietary changes are among the most significant factors in the increase in NCDs. These operate through multiple pathways, including direct nutrient and metabolic effects, epigenetic changes, 183 and more complex interactions with microbiota. 147, 184 Westernized diets are deficient in several key components, including fiber, omega-3 fatty acids, and phytochemicals; each is important in modulating the microbiome directly or indirectly, 185, 186 exacerbating inflammation through multiple pathways. 187 There are also other differences in the food sources that are not reflected merely by nutrient profiling. Fresh foods contain their own microbiome, including nonpathogenic bacteria (eg, Lactobacillus plantarum on fruits and vegetables), which have been long known to inhibit allergic responses. Importantly, these immunobiotics do not need to be alive to have an effect. 188 L plantarum from human food sources even has effects on brain and behavior in animal models. In contrast, highly processed foods contain higher levels of proinflammatory products, such as advanced glycation end products, as a result of nonenzymatic glycation and oxidation of proteins and lipids. 190 Advanced glycation end products are now recognized to affect the gut microbiome directly. 191 Additionally, artificial sweeteners and emulsifiers (eg, polysorbate-80 and carboxymethylcellulose) have all been shown to dramatically alter the microbiome in mammals, 192 as do even very low doses of contaminants, such as phthalates found in fast foods. 193, 194 For these many reasons, improving nutrition must be a key platform in improving all aspects of health because this has an effect for generations to come. Diet-induced extinctions in the gut microbiota are compounded over generations; this adds yet another new dimension to the exposome. 195 Taken together, the experimental, clinical, and population-level observations lend granularity to the clear effect of altered environmental ecology on the many habitats within and on the human body. Examining the internal ecosystem as a product of the entire external ecosystem provides a paradigm shift in attempts to prevent and treat chronic disease. Thus although a personalized view of therapeutic interventions, including nutrition, is key, 196 it is equally important to examine the wider determinants of planetary health at the same time. 19 
ENVIRONMENTAL CHANGES
Improvements in child health over the past 3 decades have seen a global switch from early death from communicable diseases to life lived with disability because of chronic NCDs, [197] [198] [199] many of which have both an environmental and immunologic basis. There is an increasing recognition that adverse environmental exposures in early life are major contributors to NCDs. Chronic diseases, such as asthma, obesity, and cardiovascular disease, were once the ''privilege'' of those living in high-income countries. However, children and adults living in low-and middle-income countries are now increasingly experiencing these NCDs. 200 Environmental stressors that contribute to NCDs include ambient air pollution; indoor air pollution, primarily from burning biomass fuel for cooking and heating in low-and-middle income countries; widespread use of pesticides and agricultural chemicals; and industrial chemicals and exposure to hazardous waste, including improper practices in recycling electronic waste in the informal sector. [200] [201] [202] [203] [204] [205] Perhaps the most avoidable environmental exposure that has major effects on child health, chronic disease, and immune development is tobacco smoking, especially during pregnancy. 206, 207 Not all environmental stressors are manmade. High levels of arsenic occur in drinking water in parts of the world, especially Bangladesh and parts of Southeast Asia, 206 cause chronic respiratory disease and cancers.
Many chemical exposures are thought to adversely affect immune development and function. Legacy chemicals, such as polychlorinated biphenyls (PCBs), which enjoyed widespread use as industrial coolants and lubricants in the 20th century, are generally immunosuppressive. There is strong evidence that many different organic chemicals alter immune system development. 208 Many persistent organic pollutants, such as dioxins/ furans, PCBs, and chlorinated pesticides, such as dichlorodiphenyl-trichlorethane and its metabolite, dichlorodiphenyldichloroethylene, are immunosuppressive. As a consequence, children with increased exposure have higher rates of otitis media and respiratory tract infections 209, 210 and poorer response to vaccinations. 211 The immunosuppression has been related specifically to dioxin-like activity, as reflected in the dioxin toxic equivalent levels. Van Den Heuvel et al 212 reported that dioxin toxic equivalent levels were significantly and negatively correlated with specific IgE levels for cat, dust mite, and grass pollen, as well as reported allergies, bronchial wheezing, and asthma in adolescents. However, the same study found a positive relationship between asthma and total PCB concentrations (odds ratio, 2.12; P 5 .05).
Many chemicals and plant-based products have endocrinedisrupting activity and significant adverse consequences on human health. This is especially true when exposure occurs during fetal development. 213 Many modern chemicals have endocrine-disrupting activity, including plasticizers, flame retardants, and pesticides. A major issue with understanding the health effects of such chemicals is that they are ubiquitous, and finding an unexposed control group is impossible. 214 In addition, exposure occurs at low doses, and study is further complicated by many of these chemicals having nonmonotonic dose-response curves. 214 Considerable controversy surrounds some of these chemicals, especially the plasticizers bisphenols and phthalates. These chemicals can act on multiple pathways and have multiple modes of action and multiple postulated or proved adverse health effects (Fig 5) .
Exposure to hazardous waste has the potential to cause adverse health effects. Children living near waste sites that contain PCBs in New York State have increased health care use for asthma and respiratory tract infections compared with those living near waste sites that do not contain PBCs. 215 It has been postulated that inhalational exposure to volatilized PCBs is responsible for this finding. 215 Disposal of end-of-life electronic products has become a major issue in recent years. 216 Recycling to regain component metals, including copper, and rare earth ingredients provides income for impoverished communities in Ghana, China, India, and parts of Southeast Asia. Unfortunately, much of this recycling occurs as cottage industries often carried out by women and children in their homes without any protection against hazardous exposures. Recycling techniques include burning of plastic-covered cables to recover copper, unsoldering of circuit boards to recover components, and recovery of industrial coolants and refrigerants. Without proper protection, the women and children are exposed to a vast array of toxicants, including lead and other metals, dioxins and furans, and complex mixtures of chemicals. The adverse effects have not been well studied, but the evidence that exists shows adverse effects on immune development, thyroid dysfunction, and increases in respiratory diseases and neurodevelopmental and behavioral disorders. 216 Understanding and reducing adverse environmental exposures can improve human health, as shown by improved health outcomes after improvements in air quality. 217 In the broadest sense, pollution is potentially avoidable but will take considerable effort and funding.
RAPID EMERGENCE OF BIG DATA AND BIOINFORMATICS TO INVESTIGATE THE EXPOSOME
The exposome in early life and its effects on immune development and healthy maturation exemplify the complexity modern-day computational and analytic techniques were meant to J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER 1 tackle. The last few decades have witnessed stunning advances in computation that have brought previously unattainable clinical and research goals within reach, in turn stimulating the generation of massive-scale data sets to power sophisticated analytics. Current bioinformatic data sets are well into the terabyte scale of storage, creating complications in day-to-day data management and analysis. However, consistent reductions in computing infrastructure cost and the emergence of cloud computing services have alleviated most of this burden. Bioinformatics has been further empowered by widespread collaboration, data sharing, and open-source software and analysis pipelines. All of these aspects facilitate the rapid progression of a field that is moving toward yet more sophisticated integrative analyses of genomic, transcriptomic, epigenomic, metabolomic, and microbiome data (integrative -omics), which, as recent studies show, have the capacity to uncover previously unknown and unmeasurable effects of the exposome.
The human genome has been shown to play a key role in the response to environmental exposures. Recent cohort studies have shown that genetic variants are associated with viral respiratory illness susceptibility, asthma control, and asthma exacerbations in childhood. 218, 219 Genetic variants that model cell type-specific transcriptional responses to microbial perturbations, such as LPS and influenza antigen, have also been uncovered, some of which also predict inflammatory diseases, such as systemic lupus erythematosus. 220, 221 GWASs have also established the widespread genetic control of circulating metabolites 222, 223 and gut microbiota. 224 Epigenomics, modifiable changes to chromosomes, such as histone acetylation or DNA methylation patterns, offer another way in which the exposome can influence gene expression. Some exposures might have transgenerational effects through epigenetic modification, such as prenatal tobacco or alcohol exposure. [225] [226] [227] Although such studies are still in their infancy, the role of big data and statistical methods that appropriately account for the hierarchical and sometimes circular nature of genomic, epigenomic, and transcriptomic data are critical to disentangling the sources of variation associated with individual response. Integrative analyses incorporating multiple -omics data are necessary to capture exposome-associated variation directly related to the human genome, as well as the metabolome and microbiota. 228 For these integrative studies, inference of causality is a key challenge. Although causal inference in human subjects remains difficult, Mendelian randomization is a popular technique to construct genetic instrumental variables. 229, 230 Microbial exposures add an additional layer of complexity in which host responses can be conditional on genetic or nongenetic microbial variation. For example, variation in the phoPQ 2-component system in Salmonella species elicits differential type I interferon responses in human DCs. 231 Of particular note, recent studies are just now establishing the widespread interactions between human microbiota and myriad dietary, lifestyle, and medication-related factors 232, 233 ; however, the consistency of these relationships in childhood is yet to be elucidated (Fig 6) .
From a methodological view, the multifactorial nature of the exposome and the spatiotemporal dynamics of the molecular and cellular networks comprising the developing human necessitate sophisticated (un)supervised learning approaches. Although approaches, such as principal components analysis and Bayesian networks, have been used extensively, it is likely that recent advances in deep neural networks might be necessary to fully leverage information in the data with applications for event or chronic disease prediction 234 and drug development. Finally, a new generation of large-scale collaborative science is creating a framework that might have transformative ramifications for future studies of individual exposures and the immune system. The Human Cell Atlas 236 is a worldwide collaborative project that aims to create reference maps of all cell types and their relationships with disease. Advances in single-cell sequencing, particularly transcriptomics, have made possible the comprehensive, cost-efficient profiling of many millions of cells 237 under basal conditions and after stimulation to myriad environmental exposures. 238 Together with algorithms for reconstruction of the molecular networks in each cell state, 239 the Human Cell Atlas might yield unprecedented insight into the multicellular and multidimensional mechanisms triggered by the exposome, many of which are presently unknown.
CONCLUSION
The development of NCDs, including allergic conditions, is the result of a complex interplay between genetically predisposing factors and environmental living conditions. The complexity of environmental exposures (over time) has now been well established. The combinatorial network of these factors is termed the exposome. Many of these exposomal conditions and factors operate in a longitudinal fashion over time and have a strong effect on the development of microbial communities at the skin and mucosal sites. The strong effect of such microbial communities on immune maturation, tolerance development, and, conversely, disease manifestation has now been well established (Tables I and II) . The future challenge lies in integration of this multidimensional interplay, which is further complicated by (1) transgenerational effects and (2) factors operating in a longitudinal fashion over time. A further challenge is the integration of -omics data, including the exposome, to build a regulatory network aimed at identifying central hubs and checkpoints that could be used as preventive (and therapeutic) targets (Table III) . Major challenges are ahead of us! onset is believed to be the first few years of life, some aspects of immune function do not mature until at or after puberty, and the relevance of these to disease pathogenesis is unknown. d The molecular and cellular mechanisms regulating microbe-immune system and microbe-metabolism interaction are still poorly understood. d An interpreted view of host-environment interactions, also in a spatial fashion, needs to be developed. d Biomarkers need to be identified and validated to monitor key components of the exposome.
